Clinical trials
Stomach Neoplasms trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 9 |
| Active, not recruiting | 7 |
| Recruiting | 6 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| Instituto do Cancer do Estado de São Paulo | 5 |
| Amgen | 3 |
| AstraZeneca | 3 |
| Bristol-Myers Squibb | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Daiichi Sankyo | 2 |
| Eli Lilly and Company | 2 |
| Universidade Federal de Pernambuco | 2 |
| AC Camargo Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 47 |
| Adenocarcinoma | 6 |
| Esophageal Neoplasms | 6 |
| Pancreatic Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Carcinoma | 2 |
| Head and Neck Neoplasms | 2 |
| Kidney Neoplasms | 2 |
Trials
Showing 76 to 47 of 47. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.